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Abstract
Background: Single-cell technologies are transforming biomedical research,
including the recent demonstration that unspliced pre-mRNA present in single-cell
RNA-Seq permits prediction of future expression states. Here we apply this RNA
velocity concept to an extended timecourse dataset covering mouse gastrulation
and early organogenesis.
Results: Intriguingly, RNA velocity correctly identifies epiblast cells as the starting
point, but several trajectory predictions at later stages are inconsistent with both
real-time ordering and existing knowledge. The most striking discrepancy concerns
red blood cell maturation, with velocity-inferred trajectories opposing the true
differentiation path. Investigating the underlying causes reveals a group of genes
with a coordinated step-change in transcription, thus violating the assumptions
behind current velocity analysis suites, which do not accommodate time-dependent
changes in expression dynamics. Using scRNA-Seq analysis of chimeric mouse
embryos lacking the major erythroid regulator Gata1, we show that genes with the
step-changes in expression dynamics during erythroid differentiation fail to be
upregulated in the mutant cells, thus underscoring the coordination of modulating
transcription rate along a differentiation trajectory. In addition to the expected block
in erythroid maturation, the Gata1-chimera dataset reveals induction of PU.1 and
expansion of megakaryocyte progenitors. Finally, we show that erythropoiesis in
human fetal liver is similarly characterized by a coordinated step-change in gene
expression.
Conclusions: By identifying a limitation of the current velocity framework coupled
with in vivo analysis of mutant cells, we reveal a coordinated step-change in gene
expression kinetics during erythropoiesis, with likely implications for many other
differentiation processes.
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Background
Cellular differentiation into diverse cell types underpins all metazoan development.
Moreover, cellular differentiation processes are also crucial for stem cell-mediated tis-
sue maintenance, and their perturbation has been implicated in ageing-associated re-
generative failure as well as malignant transformation [1, 2]. Since cellular
differentiation decisions are made at the level of individual cells, elucidation of the
underlying molecular mechanisms requires the use of single-cell approaches. It is no
surprise therefore that recent innovations in single-cell molecular profiling technologies
have been embraced rapidly by developmental and stem cell biologists, with complete
single-cell gene expression maps now available for developing embryos of several model
organisms ([3–5], reviewed in [6]), as well as large-scale datasets covering adult tissue
homeostasis [7–9].
Comprehensive molecular profiling necessarily entails the generation of snapshot
data, because cells need to be fixed to examine their molecular content. This in turn
represents a major drawback for the study of differentiation processes, which com-
monly occur over extended timeframes via complex trajectories underpinned by intri-
cate decision-making processes. Much excitement was therefore generated by a recent
seminal study [10], which demonstrated that unspliced pre-mRNA present in scRNA-
Seq datasets can be exploited to predict likely future expression states. This so-called
RNA velocity concept is based on the notion that the ratio between unspliced and
spliced RNA differs depending on whether a gene is in the process of being up- or
downregulated. During upregulation, there is a relative increase in newly transcribed
unspliced RNA, with the converse occurring during downregulation. The RNA velocity
framework has rapidly gained traction across the wider single-cell community, being
applied across multiple experimental systems [11–13], and also extended as part of the
scVelo analysis suite [14], which allows inclusion of genes whose transcript levels are
not in steady state.
One system where the RNA velocity concept has particular potential is erythropoi-
esis, the process whereby oxygen-transporting red blood cells are generated from multi-
potent hematopoietic progenitors. Research into the transcriptional control processes
of erythropoiesis led to several paradigmatic discoveries, including the dissection of dis-
tal transcriptional control elements [15–17], as well as antagonistic transcription factor
pairings as executors of lineage choice in multipotent progenitors [18]. During embryo-
genesis, a first so-called primitive wave of erythropoiesis occurs in the yolk sac,
followed by a second definitive wave, initiated also in the yolk sac, then predominantly
in the fetal liver and later in the adult bone marrow [19]. The zinc finger protein Gata1
represents the archetypal erythroid transcription factor and is required for the matur-
ation of both primitive and definitive erythroid cells [20–23], as well as megakaryocyte
maturation [24]. However, the precise molecular processes affected by Gata1 deletion
in early embryonic erythropoiesis have remained obscure, principally because conven-
tional biochemical methods are unsuitable for the very small number of cells present at
these early developmental stages.
Here, we have applied RNA velocity to a recently published scRNA-Seq dataset of
nine sequential timepoints, spaced 6 h apart, which encompass mouse gastrulation and
early organogenesis [25]. We observed that some of the inferred trajectories are incom-
patible with the existing biological knowledge, as well as with the real-time ordering
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derived from the sequential sampling timepoints. For erythroid differentiation in par-
ticular, we show that failure of the velocity framework is due to a concerted increase in
transcription rate of a subset of erythroid genes, midway through the red blood cell
maturation trajectory. Analysis of Gata1− chimeric embryos underscores the concerted
nature of this expression boost downstream of Gata1.
Results
Limitations of RNA velocity trajectory inference at organismal scale
To evaluate RNA velocity-based trajectory inference with a complex dataset, we applied
the scVelo analysis pipeline [14] to a recently reported timecourse scRNA-Seq dataset
covering mouse gastrulation and early organogenesis. This mouse gastrulation atlas
contains approximately 120,000 single-cell transcriptomes across nine sequential time-
points covering 37 major cell types [25]. Prior to scVelo analysis, we removed extraem-
bryonic ectoderm and extraembryonic endoderm cells, as they derive from early lineage
branching events that are not covered in this dataset. We first applied scVelo to the
normalized and batch-corrected count matrix across all embryonic stages (Fig. 1A). We
observed that scVelo correctly identifies the epiblast population as the origin of the glo-
bal differentiation processes that occur during gastrulation and early organogenesis. In
relation to the more differentiated cell types however, there were several instances
where scVelo had difficulty in capturing some of the highly complex differentiation
events that occur across the entire embryo. For instance, scVelo predicted that E8.0 al-
lantois and mesenchyme cell types give rise to mesodermal cells from earlier timepoints
rather than the E8.25/E8.5 allantoic and mesenchymal cells. Another inconsistency oc-
curred with E8.0–E8.25 endoderm cells, which were predicted to give rise to E6.5–E7
visceral endoderm, rather than the other way round. Most noteworthy, scVelo failed to
recapitulate the erythropoiesis branch, where it predicts a backwards differentiation
from later to earlier populations. We next repeated this analysis using data from each
individual timepoint (Fig. 1B; shown are E7.5 and E8.5). We saw that the pipeline ac-
curately recapitulates known biological trajectories up to E7.5, but observed the same
inconsistency from E7.75 to E8.5, with scVelo arrows pointing backwards.
Taken together therefore, we have identified that for erythroid development, the out-
put of scVelo is inconsistent with the timecourse information gathered from the experi-
mental design of the gastrulation atlas.
Unspliced sequence reads help to discriminate between cell types
We next asked whether this issue is due to a general lack of biologically meaningful in-
formation captured in the unspliced reads.
To this end, we exploited two variance-based dimensionality reduction methods,
principal component analysis (PCA) and Multi-Omics Factor Analysis (MOFA [26]), to
interrogate how much inter-population variability is explained by the spliced and
unspliced information layers, whether considered separately or together. Upon compar-
ing PC1 and PC2 (or MOFA Factors 1 and 2), in addition to the expected lineage sep-
aration obtained using the spliced reads (Fig. 2A, left panel), we could also observe a
degree of lineage separation when using the unspliced reads alone (Fig. 2A, middle
panel). In addition, we saw a qualitatively improved separation of the different lineages
Barile et al. Genome Biology          (2021) 22:197 Page 3 of 22
when spliced and unspliced information is used in combination (Fig. 2A, right panel;
see Additional file 1: Fig. S1 for further components/factors). Moreover, the MOFA fac-
tors account for 16% of variation in the spliced data and 4% of the variation in
unspliced data (Fig. 2Bi). Interestingly, a closer look at the MOFA pre-processing and
final outcome showed a minor overlap of genes that are highly variable with respect to
spliced or unspliced counts (Fig. 2Bii) and a different weight contributed by the two
layers to the final factors (Fig. 2Biii).
Fig. 1 Inferring differentiation trajectories at organismal scale. A Pijuan-Sala et al. [25] layout containing
single-cell transcriptomes from E6.5 to E8.5, colored by sampled timepoint (left) and by cell-type (right). The
overlaying arrows result from applying the scVelo pipeline to the whole embryonic dataset and represent
inferred developmental trajectories. Arrowheads highlight the erythroid branch, displaying scVelo trajectory
predictions that are inconsistent with real-time sampling. B Pijuan-Sala et al. [25] layout highlighting single-
cell transcriptomes belonging to E7.5 (left) and E8.5 (right) and colored by cell-type (see legend in A). The
overlaying arrows result from applying the scVelo pipeline to these individual timepoints and represent
inferred developmental trajectories. Arrowheads highlight the erythroid branch
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Multiomics factor analysis therefore not only demonstrates that the unspliced reads
in the gastrulation atlas dataset contain biologically relevant information, but also sug-
gests that integrated analysis of spliced and unspliced reads may more broadly facilitate
the interpretation of complex scRNA-Seq datasets.
Analysis of unspliced reads reveals complex expression kinetics
Having confirmed the utility of unspliced reads, we next explored whether the inability
to recover real-time progression in whole embryo trajectory inference using scVelo
might be related to the assumptions made by the current RNA velocity analysis tools.
The derivation of gene-specific expression kinetics underpins the scVelo analysis pipe-
line, as illustrated by so-called phase plots that depict the amounts of spliced versus
unspliced reads within a population of cells [14]. If a gene is upregulated during a dif-
ferentiation timecourse, cells will be placed above the diagonal between no expression
and maximum expression due to the relatively larger amount of newly produced pre-
mRNA during the gene induction process, while the converse is true for downregulated
genes (Fig. 3A). Both of these scenarios are readily captured by scVelo, with the pre-
dicted vectors of differentiation agreeing with the actual temporal progression. If a
given gene however experiences an increase in transcription rate midway through a dif-
ferentiation timecourse, the sudden increase in unspliced pre-mRNA will result in a
phase plot that may be wrongly classified by scVelo, with predicted vectors of
Fig. 2 Unspliced counts contribute to explaining the variability among cell types. A Dimensionality
reduction with the first two principal components/MOFA factors using spliced reads alone (left), unspliced
reads alone (middle), and both spliced and unspliced (right). Single-cell transcriptomes are colored by cell-
type annotation; see Fig. 1 for full legend. B MOFA characterization of spliced and unspliced reads assessing
proportion of variance explained (i), overlap in highly variable genes calculating using either spliced or
unspliced reads (ii), and factor weight distributions (iii)
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differentiation diametrically opposed to the true direction of differentiation (Fig. 3A).
This is indeed what we observed when inspecting the phase plots of the scVelo driver
genes (top-likelihood genes, Additional file 2: Table S1), which display a steep increase
of unspliced counts in the Erythroid 3 population, leading to a reverse velocity predic-
tion, progressing from Erythroid 3 to earlier populations (Additional file 1: Fig. S2A).
We next set out to identify all genes exhibiting this rapid increase in expression levels
in the Erythroid 3 population (Fig. 3B). After fitting a linear regression through each
population and each gene and testing whether the inferred slopes reflected the expected
order based on biological knowledge, we found 89 such genes, which we termed mul-
tiple rate kinetics or MURK genes. These genes included Smim1, coding for the Vel
Fig. 3 A set of genes with complex expression kinetics confounds velocity estimation in erythropoiesis. A
Illustration of phase plot representation in datasets of differentiating cell populations, and associated scVelo
predictions. B Illustration of strategy for MURK gene identification. C Phase plots of representative MURK
genes. x-axis: normalized imputed counts of spliced transcript; y-axis: normalized imputed counts of
unspliced transcript. D GO-term enrichment of MURK genes identified in mouse yolk sac erythropoiesis. E
Zoomed-in UMAP of the erythroid branch (see Fig. 1 for full UMAP) with scVelo calculations, before and
after removing MURK genes identified in B. Distinct waves of embryonic erythropoiesis are visible upon
MURK gene removal, highlighted with arrowheads
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Blood Group Antigen [27], and Hba-x, where we could confirm an increase in expres-
sion kinetics using phase plots (Fig. 3C).
Having identified a set of genes with a coordinated increase in expression rate mid-
way through erythropoiesis, we next asked what function these genes might play in the
broader transcriptional program of red blood cell maturation. Visual inspection of the
gene list revealed it to contain archetypal red blood cell genes including the globin
genes Hba-x, Hbb-a1, Hba-a2, Hbb-bt, Hbb-bh1, and Hbb-y (Additional file 3: Table
S2). Unsupervised gene ontology analysis confirmed that biological functions essential
for red blood cells were highly enriched, including “gas transport” and “heme biosyn-
thetic process” (Fig. 3D).
We next removed this set of MURK genes and recalculated the RNA velocity-
inferred trajectories. As can be seen in Fig. 3E, inferred vectors of differentiation are
now in good agreement with the real-time progression of erythropoiesis.
The scVelo suite also calculates a so-called latent time, which represents the pseudo-
time ordering hidden in the spliced and unspliced dynamics, and is more powerful than
previously described pseudotime inferring approaches since it incorporates both the
gene dynamics and the spliced and unspliced information [14]. Using the full gene set,
the latent time calculation for the erythroid lineage is contrary to the know progression
of erythroid differentiation (Fig. 3E left panels, Additional file 1: Fig. S2B, left panels).
By contrast, removing the MURK genes results in a latent time prediction that is not
only consistent with the major axis of erythropoiesis, but also identifies the two sequen-
tial inputs described previously [25], namely an early wave directly from posterior
mesoderm as well as a second wave coming from yolk sac hemogenic endothelium (see
Fig. 3E, Additional file 1: Fig. S2B, right panels).
Taken together therefore, this analysis shows that inconsistent RNA velocity-inferred
trajectories can be remedied by the removal of genes with complex expression kinetics.
Erythroid multiple rate kinetics genes are essential for red blood cell function
To corroborate upregulation of our identified MURK genes during erythropoiesis, we
interrogated a previously published dataset with transcriptomic analysis of a loss of
function model for the erythropoiesis master-regulator Gata1 [28]. In vitro differenti-
ation of Gata1 knockout embryonic stem cells over-expressing human BCL2 can pro-
duce permanently self-renewing immature erythroid progenitor cell lines. One such
model, G1ER, contains a tamoxifen-inducible Gata1 transgene, the activation of which
triggers erythroid maturation ([29, 30]; Fig. 4A). Microarray-based differential gene ex-
pression was performed, comparing the uninduced and induced conditions [28]. In
total, 76 of our 89 MURK genes overlapped with the genes identified by this
microarray-based comparison. Of those, 64 were upregulated, of which 55 showed
strong upregulation, 4 were downregulated, and 8 showed no change in expression fol-
lowing induction of Gata1 in the G1ER system, demonstrating a highly significant over-
lap of our identified MURK genes with the G1ER-induced genes (p < 10−24 ; see
Fig. 4B).
Our newly identified erythropoietic MURK genes therefore perform key roles in red
blood cell function, and their upregulation was validated in an independent model of
red blood cell maturation.
Barile et al. Genome Biology          (2021) 22:197 Page 7 of 22
scRNA-Seq of mouse chimeras reveals the early cellular defects in Gata1 loss of function
The G1ER cell line represents an in vitro model, and the published differential gene ex-
pression data were from bulk microarray profiling, thus precluding any analysis of
single-cell gene expression kinetics. We therefore turned to our recently reported
Chimaera-Seq approach, whereby scRNA-Seq is coupled with mouse chimeric embryo
technology, to define both cellular and molecular consequences of gene knockouts
in vivo [25, 31]. We used our standard embryonic stem cells (ESCs) expressing a
Fig. 4 In vivo analysis of Gata1 function using a chimaera assay coupled with scRNA-Seq. A Schematic of
the G1ER system [29, 30]. B Behavior of the 89 MURK genes identified in Fig. 3 upon Gata1 induction in the
G1ER system [28]. Wu et al. report that upon Gata1 induction they obtained a total of 2769 upregulated
genes, 6079 mildly upregulated, 3566 downregulated, and 3445 with no response. C UMAPS of Gata1−
chimera cells allocated a hemato-endothelial identity colored by cell-type (sub-clusters defined in Pijuan-
Sala et al. [25]—BP: blood progenitors, EC: endothelial cells, Haem: hemato-endothelial progenitors, Mk:
megakaryocytes, My: myeloid cells, Ery: erythroid cells) and split by genotype. Orange arrowheads highlight
increased population with megakaryocytic signature in Gata1− fraction. D UMAPS of Gata1− chimera cells
allocated a hemato-endothelial identity colored by sampling timepoint and split by genotype. E Barplots
with the quantification of chimera cells mapping to each hemato-endothelial lineage of the reference
dataset (left) and to sampled timepoints of the reference dataset (right)
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constitutive tdTomato (tdTom) fluorescent marker gene to generate a Gata1 knockout
line (see “Methods”). Gata1− tdTom+ cells were injected into tdTom− wildtype blasto-
cyst and transferred into pseudo-pregnant females, resulting in chimeric embryos that
we harvested at E8.5. Six chimeric embryos were pooled, dissociated into a single-cell
suspension, and tdTom+ and tdTom− cell fractions were sorted for scRNA sequencing.
We obtained 8420 tdTom− and 7944 tdTom+ cells passing quality control and assigned
to a cell type, with an average of 4354 genes being detected per cell.
We then concatenated the chimera data with the Pijuan-Sala et al. [25] reference
dataset and mapped nearest neighbors (see “Methods”). We observed an overall homo-
geneous distribution of both mutant and wildtype fractions throughout the later time-
points of the landscape, except for the erythroid branch. Indeed, we observed a block
in the erythroid lineage of the mutant cells, which were over-represented in the start of
the erythroid differentiation branch, while their wildtype counterparts were present
throughout erythroid differentiation (Additional file 1: Fig. S3). Identification of the
nearest neighbours of chimeric cells within the reference dataset allowed their quick
cell-type annotation, which we used to quantify the differences in the hemato-
endothelial cell-type representation within the chimera fractions. This analysis con-
firmed a severe erythroid differentiation defect of the mutant cells (Fig. 4C–E). When
examining the reference dataset sampled timepoint of the chimera nearest neighbours,
we also observed a temporal shift within the erythroid lineage, with tdTom+ mutant
cells mapping to earlier timepoints than their wildtype tdTom− counterparts, further
confirming a developmental block of the mutant cells (Fig. 4D, E). In addition, we ob-
served that this erythroid defect was coupled with an over-representation of cells with
a megakaryocyte signature (Fig. 4C).
The newly generated Gata1− Chimaera-Seq data therefore not only recapitulated the
expected block in erythroid maturation, but also revealed an expansion of the megakar-
yocytic lineage in the E8.5 yolk sac.
The molecular program affected by Gata1 loss in early embryos
Although the role of Gata1 is well documented in developmental erythropoiesis [21,
23], the early molecular defects of Gata1 loss of function in vivo had not been reported.
The Gata1 Chimaera-Seq dataset therefore presented an opportunity to dissect the
early molecular program controlled by Gata1 in vivo. Having registered a defect in
erythroid differentiation and an increase in the megakaryocytic lineage population, we
performed differential gene expression testing between the chimera mutant and wild-
type cells in these clusters (Additional file 4: Table S3).
Regarding the megakaryocytic subset, we observed upregulation of progenitor
markers Kit, Gata2, and Myb in the Gata1− cells as well as lower expression of matur-
ation genes for the megakaryocyte lineage Gp5, Pf4, Mpl, and Plek (Fig. 5A). Hyper-
proliferative megakaryocyte progenitors, detected previously in Gata1− E12.5 fetal
livers, led to compromised platelet function and were suggested to originate in the yolk
sac [32]. Our results showing over-production of megakaryocytic cells with impaired
maturation characteristics in E8.5 Gata1− chimera yolk sacs support this notion, and
importantly place the megakaryocytic defect within the very early phase of megakaryo-
cyte formation.
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Interestingly, all hemato-endothelial cell subsets displayed upregulation of Spi1 (cod-
ing for the PU.1 transcription factor) in the Gata1− cell fraction compared to wildtype
counterpart (FDR < 0.01; Fig. 5A). Given the previously reported Gata1-PU.1 cross-
repression in adult bone marrow [18] and in zebrafish embryonic hematopoiesis [33],
we systematically assessed the effect of Gata1 knockout in the mouse chimera lineages
and observed that in Gata1− cells, Spi1 was specifically upregulated in all hematopoietic
sub-clusters, with a stronger effect on Mk and Ery1 subsets (Additional file 1: Fig. S4).
In the early erythroid subset, Ery1, we again noted that the mutant cells displayed in-
creased expression of genes characteristic of a progenitor signature. Conversely, eryth-
roid maturation hallmark genes such as Hbb-bs and Gypa were downregulated, along
with the erythroid Gata1 target Mllt3 ([34]; Fig. 5A). GO-term enrichment analysis of
Fig. 5 Gata1 chimaera assay reveals disruption of MURK genes and perturbed yolk sac hematopoiesis.
A Violin plots of representative genes differentially regulated in Gata1− hematopoietic lineages. B GO-term
enrichment of genes downregulated in Gata1− Ery1 cells compared to their WT counterparts in chimeras.
C Venn diagram showing overlap between MURK genes and genes downregulated in Gata1− Ery1 cells.
D Phase plots of MURK genes identified along erythroid differentiation, in E8.5 Gata1− chimera datasets,
colored by tdTom status
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genes downregulated in Gata1− Ery1 cells revealed biological processes essential to red
blood cell function (Fig. 5B). Furthermore, we also observed that 48% of the MURK
genes identified in Fig. 3 overlapped with these genes that fail to upregulate in Gata1−
erythroid cells (Fig. 5C; p < 10−24).
In addition to the failure of inducing genes associated with erythroid maturation,
single-cell resolution molecular analysis also revealed a striking failure to downregulate
genes associated with alternative lineage programs such as Pu.1, consistent with the no-
tion that the earliest wave of primitive hematopoiesis produces erythroid cells, mega-
karyocytes, and macrophages, with evidence for at least bipotential progenitor cells
[35].
The late erythroid increase in expression rate is downstream of Gata1 function
Having generated the Chimaera-Seq single-cell data for both wildtype and Gata1
knockout cells, we next used the ratio of spliced/unspliced reads to explore differences
in expression kinetics between the wildtype and mutant cells. As can be seen in Fig. 5D,
the previously defined MURK genes failed to display the increased rate of expression
characteristic for the later stages of erythropoiesis in the mutant cells. The examples
shown include the embryonic globin gene Hbb-y, as well as the Fam210b gene, coding
for a putative mitochondrial protein recently implicated in erythroid differentiation
([36]; Fig. 5D). This result confirms that the erythroid boost in expression forms part of
the transcriptional program downstream of Gata1 function, although it does not dem-
onstrate a direct regulatory role for Gata1.
However, preliminary modelling analysis suggests that the change observed in MURK
gene dynamics is due to altered transcription rates (see Additional file 5: Supplemen-
tary Note), indicating a close association of the coordinated late erythroid increase in
transcription rate with the molecular program downstream of transcription factor
Gata1.
A coordinated increase of expression rate during human fetal liver erythropoiesis
Having identified a coordinated increase in transcription rate during mouse yolk sac
erythropoiesis, we next wanted to ascertain whether the same phenomenon could also
be seen in human cells. Moreover, we were keen to explore an scRNA-Seq dataset gen-
erated by a different laboratory, to exclude any potential technical bias caused by our
own experimental protocols. We therefore turned to a recently published comprehen-
sive dataset of human fetal liver erythropoiesis [37], and extracted the 49388 cells anno-
tated to the four clusters encompassing human fetal liver erythropoiesis. When
calculating scVelo-based differentiation vectors as well as latent time using the full gene
set (see “Methods”), both were reversed (Fig. 6A, left plots), consistent with the mouse
yolk sac results. We therefore again ran our pipeline to discover genes with a potential
increase in expression rate along the differentiation pathway. The resulting 97 genes
again contained archetypal erythroid genes such as the hemoglobin genes (Fig. 6B),
with overall gene ontologies demonstrating a functional role in erythropoiesis (Fig. 6C,
see also Additional file 6: Table S4). We then recalculated both the scVelo differenti-
ation vectors as well as latent time after removing the fetal liver MURK genes. This re-
vealed scVelo vectors that were consistent with the expected developmental
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progression (see Fig. 6A, right plots). This analysis therefore demonstrates that complex
expression kinetics apply broadly to erythropoiesis, and their identification can be used
to amend the RNA velocity framework to prevent erroneous predictions.
Discussion
There is no doubt that single-cell molecular profiling constitutes a transformative tech-
nology. It suffers however from the major drawback that cells need to be fixed in order
Fig. 6 Concept of dual kinetics of gene expression is also revealed in human fetal liver hematopoiesis.
A UMAP representation of human fetal liver erythroid cell populations. The overlaying arrows result from
applying the scVelo pipeline using all genes (left) or after MURK gene exclusion (right). Bottom UMAPs are
colored by corresponding scVelo-inferred latent time. In order to facilitate comparison with the mouse data,
a new clustering was performed on the erythroid cells, see “Methods.” MEMP: megakaryocyte-erythroid-
mast cell progenitor. B Phase plots of representative MURK genes identified in human fetal liver
erythropoiesis single-cell RNA-Seq dataset. C GO-term enrichment of MURK genes identified in human fetal
liver erythropoiesis
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to profile them, with the consequence that measurements are by necessity static snap-
shots. To decipher complex biological processes, however, temporal information is
commonly required. The single-cell RNA velocity concept raised the prospect of over-
coming some of the limitations associated with static measurements, by providing a
strategy that can infer future cellular states. The RNA velocity framework is based on
an explicit model of transcriptional processes (transcription, splicing, degradation). The
notion that physical parameters of gene expression can be deduced from single-cell
gene expression data had been explored before the single-cell RNA velocity concept
was introduced [38, 39]. However, the scVelo implementation provided an attractive
framework for estimating gene-specific expression parameters by taking advantage of
the spliced versus unspliced read counts across large cell populations [14]. Using
erythropoiesis as an example, we show here that this current framework needs to be
adapted to accommodate more complex expression kinetics. Importantly, our analysis
revealed that sets of genes can show a coordinated increase in transcription rate along
a differentiation pathway. Moreover, deletion of the key erythroid regulator Gata1 abro-
gated this coordinated change in expression dynamics, thus revealing this increase in
transcription rate as an important feature of erythropoiesis.
As to the precise mechanisms, at this stage we can only confidently assert that this
coordinated change in expression dynamics occurs downstream of Gata1 during
erythropoiesis. Of note, comprehensive analysis of the G1ER erythroid differentiation
model has shown that Gata1-induced maturation triggers increased enhancer/promoter
interactions for upregulated genes and that the most highly enriched motif in the pro-
moters of these genes are GATA sites [40]. These observations are therefore consistent
with the lineage-determining function of Gata1 involving a coordinated increase in ex-
pression kinetics of a set of genes important for red blood cell function.
Our observations regarding the Gata1 knockout phenotype also warrant some discus-
sion. With embryonically lethal phenotypes such as Gata1 knockout, conventional ana-
lysis tends to be somewhat limited, since the embryos are dead because they have no
red blood cells. By contrast, the Chimaera-Seq assay enables both quantification of cell
numbers and characterization of their molecular profiles. Moreover, there are no sec-
ondary effects caused by the dying embryo, because the wildtype host cells rescue over-
all fetal development, thus allowing a focused analysis of cell-intrinsic molecular
defects. One noteworthy observation from our data is that erythroid differentiation pro-
ceeds substantially beyond the stage where Gata1 expression itself is first initiated, but
fails to proceed to the late erythroid phase where expression of canonical red blood cell
genes is greatly upregulated. However, gene expression prior to the differentiation
block is not normal. In particular, we observed increased Spi1/Pu.1 in the Gata1 knock-
out cells, consistent with the previously reported [18] but also disputed [41] antagonis-
tic relationship between Gata1 and Pu.1.
Within hematopoiesis, Pu.1 is recognized as a key regulator of myeloid and T cell lin-
eages, but not erythroid cells, even though a role in the proliferation of immature
erythroid progenitors has been reported ( [42], reviewed in [43]). Upregulation of Pu.1
in our immature Gata1 knockout cells therefore suggests that these cells of the primi-
tive hematopoietic lineage represent progenitors with multilineage potential, rather
than being restricted to just the red cell lineage. Further evidence for this notion is pro-
vided by our observation that the reduction in erythroid cells in the Gata1 knockout is
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accompanied by an increase in megakaryocyte progenitors, consistent with a model
whereby Gata1 levels influence the lineage choice decisions of a multipotent progenitor
cell.
Our observation of an expanded pool of megakaryocyte progenitors may also be of
direct relevance to our understanding of the pre-leukemic transient myeloproliferative
disease (TMD) that is prevalent in newborns with trisomy 21 [44]. TMD is thought to
arise when a fetal-specific hematopoietic progenitor cell with trisomy 21 acquires a par-
tial loss of function mutation in GATA1, resulting in a short form of GATA1
(GATA1s). TMD is characterized by expansion of immature megakaryocyte progeni-
tors, and in 10 to 20% of cases transforms into malignant acute megakaryoblastic
leukemia (reviewed in [45]). Over-expression of GATA1s in mouse models resulted in
the identification of mid-gestation fetal liver megakaryocyte progenitors as uniquely
sensitive to this mutant GATA1s form compared to their adult bone marrow counter-
parts [46]. The over-represented population of immature megakaryocytic progenitors
in our E8.5 Gata1− chimeras may correspond to the developmental emergence of this
transient precursor, TMD-initiating cell, in the yolk sac.
Application of the single-cell RNA velocity concept has commonly been “confirmatory”,
whereby a differentiation path proposed by other means was shown to be consistent with
RNA velocity inference. When we applied the RNA velocity framework to the entire
mouse gastrulation atlas, some inferred vectors of differentiation agreed with our current
understanding of developmental biology, but others disagreed. Deeper interrogation of
predictions that conflicted with our current understanding of erythropoiesis showed that
the RNA velocity predictions could not be correct, not only because they ran counter to
the known expression changes that accompany red blood cell differentiation, but also be-
cause they contradicted the real-time sampling of the data. Our results thus highlight cer-
tain limitations of the current implementation of this framework for identification of
novel trajectories. Importantly however, it is through our observation of the inconsistent
predictions that we were led to identify the previously unrecognized dynamic nature of
the transcriptional control of erythropoiesis. Our extension to the scVelo implementation
reveals the presence of such time-dependent changes of gene expression parameters and
retrieves the concerned MURK genes in developmental trajectories of interest. To verify
whether other developmental processes beyond erythropoiesis may involve time-
dependent changes of gene expression parameters, we interrogated two additional trajec-
tories where application of scVelo to the whole Atlas reference had resulted in arrow pre-
dictions contrary to real-time progression (see Additional file 1: Fig. S5). These analyses
led us to conclude that (1) MURK genes are not restricted to erythropoiesis but can be
found across multiple trajectories, including where scVelo predictions are correct; (2)
scVelo predictions are highly sensitive to which subset of cells/genes are used for the ana-
lysis, which will be different when the landscape is considered as a whole vs when a spe-
cific trajectory is isolated; (3) Removal of MURK genes can improve predictions and is
therefore advisable when the true direction differentiation is not known; (4) Overall, a
great degree of caution needs to be used with the interpretation of scVelo output; (5)
Going forward, rather than simply eliminating MURK genes, future incarnations of the
Velocity framework should accommodate the possibility of dynamic changes in parame-
ters, whereby the identification of dynamically changing rates of gene expression may
illuminate previously unrecognized aspects of the underlying biological processes.
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One of the major attractions of current usage of the RNA velocity framework is that
the added information on unspliced reads comes essentially “for free,” as it is extracted
from the raw scRNA-Seq counts. It is however worth remembering that technologies
reliant on oligo dT priming are not designed to capture intronic reads with high effi-
ciency, a problem exacerbated when using current droplet methods that sequence spe-
cifically either the 3′ or 5′ ends of genes, but not the rest. A likely reason for the
capture of intronic reads may be the priming of oligo dT onto small stretches of A
present in introns, but there certainly seems scope for the development of future
methods specifically designed to increase the capture of unspliced / intronic sequences.
It is noteworthy however that our MOFA analysis in Fig. 2 fully supports the notion
that even with current datasets, the unspliced reads alone provide a degree of lineage
discrimination and contribute to a substantial proportion of the variance when used
together with the spliced reads.
Of note, current RNA velocity frameworks consider only a single reason for the pres-
ence of introns, namely that a pre-mRNA has not been fully processed. However, it is
known that other processes such as intron retention can result in the presence of in-
tronic sequences in otherwise fully processed cytoplasmic mRNA molecules [47, 48].
Furthermore, splicing heterogeneity and variable splicing kinetics, known to play an im-
portant role both in normal and pathological contexts (reviewed in [49]), need to be
taken into account as potential confounders when applying the RNA velocity frame-
work. A more granular approach towards both the modelling and experimental analysis
of spliced versus unspliced reads thus represents a promising avenue for future
research.
Conclusions
Taken together, this study reports how the RNA velocity framework can be extended
to delve into the transcriptional mechanisms of tissue differentiation, complemented
with single-cell resolution and in vivo analysis of Gata1 function, which revealed a





To obtain separated count matrices for spliced and unspliced mRNAs, we ran velocyto
0.17.17 [10] on the .bam files from the mouse atlas in Pijuan-Sala et al. ([25]; Arrayex-
press accession number: E-MTAB-6967). We kept all cells that passed the QC as de-
scribed in the original publication, but filtered out from downstream analysis the
extraembryonic tissues: ExE endoderm, ExE ectoderm, and Parietal endoderm as well
as samples with no timepoint allocation (labelled as “mixed gastrulation”). To select
highly variable genes (HVGs) we applied both the scanpy v1.5.1 and the scVelo v0.2.1
[14] pipelines. That is, we removed genes with less than 20 shared counts between
spliced and unspliced counts, before normalizing and log transforming the remaining
genes. Then, we selected the top 2500 HVGs from each approach (resulting in a total
of 4000, with 1000 overlapping genes) for further calculation of moments, while
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performing imputation using the top 30 nearest neighbours from the graph connectivi-
ties generated with the original UMAP coordinates from Pijuan-Sala et al. [25]. The
velocity vectors were computed in dynamical mode rather than steady state.
Human dataset
We first downloaded raw reads from Popescu et al. ([37]; Arrayexpress accession num-
ber: E-MTAB-7407), and aligned them against the human genome hg19-3.0.0 with
CellRanger v3.0.2 to generate the .bam files and obtain separated count matrices for
spliced and unspliced mRNAs as described above. We filtered out cells with less than
3550 counts, less than 900 genes and more than 6% mitochondrial counts. Again, we
combined scanpy and scVelo’s pipelines to select 1500 HVGs to compute PCA coordi-
nates and applied batch correction using the function reducedMNN from the batchelor
package v1.4.0 [50], followed by the estimation of velocity vectors in the same way it
was done for the mouse dataset.
MOFA+ implementation
We ran MOFA+ v1.4.0 [26] using as input the two single-cell experiment objects ob-
tained from the spliced and unspliced counts independently. Each object was created in
R using the scran v1.16.0 [51] library as follows: we started from the raw counts, nor-
malized them with factor sizes obtained after pre-clustering, log transformed, and re-
duced to 5000 HVG. We then switched to Python v3.7.4, where we regressed out the
sample effect and scaled the object to generate a MOFA+ model with standard parame-
ters. Finally, we used reducedMNN to correct the MOFA Factors for batch effects. The
same objects used as MOFA input were used for PCA calculation in Fig. 2A.
MURK gene identification
To identify MURK genes, we considered the imputed counts resulting from the scVelo
standard pipeline. Then, for each gene and each population among the Erythroid
lineage, we calculated the unspliced versus spliced slope with a linear regression, as well
as the standard error on the slope. In the mouse dataset, we selected all genes for which
the slope in Erythroid3 is significantly higher than the slope in Erythoid2 (according to
a one-sided t-test p value < 0.05), the average spliced counts in Erythroid3 is higher
than the average spliced counts in every other population, and the slope in Erythroid3
positive. We found 89 genes that respect all these criteria.
In the human dataset, in order to obtain erythroid populations more comparable to
our mouse data, we re-clustered the erythroid clusters (Fig. 6A). We retained the popu-
lation annotations from the original paper except for the Late Erythroid population,
which we defined after performing Leiden clustering on the Umap coordinates. Specif-
ically, we re-allocated a subset of the previously annotated Mid Erythroid population to
Late Erythroid, in such a way that they have a similar numbers of cells. We then calcu-
lated the unspliced versus spliced slope with linear regression and identified MURK
genes where the slope in Late Erythroid is significantly higher than the slope in Mid
Erythroid. We found 97 genes respecting these criteria.
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Gene ontology enrichment analysis
We performed gene ontology enrichment analysis using the http://geneontology.org
website comparing the MURK genes against all biological processes, with the default all
Mus musculus genes in database as background set [52, 53]. We ranked the processes
by FDR.
Overlap testing
Overlap was tested with Fisher exact test. We calculated the probability of having m =
55 genes of our n = 89 MURK genes mapping to the A = 1022 high response genes
(out of N = 4195 genes) in the Wu et al. [28] publication (GEO accession number:
GSE30142) as the probability of randomly picking m elements of a specific type when
randomly choosing n elements out of N, where the frequency of the special type is A/
N.
Gata1− chimera dataset generation and analysis
Embryo collection
All procedures were performed in strict accordance to the UK Home Office regulations
for animal research under the project license number PPL 70/8406.
Chimera generation
TdTomato-expressing mouse embryonic stem cells (ESC) were derived as previously
described [25]. Briefly, ESC lines were derived from E3.5 blastocysts obtained by cross-
ing a male ROSA26tdTomato (Jax Labs – 007905) with a wildtype C57BL/6 female, ex-
panded under the 2i + LIF conditions [54] and transiently transfected with a Cre-IRES-
GFP plasmid [55] using Lipofectamine 3000 Transfection Reagent (Thermo Fisher Sci-
entific, #L3000008) according to manufacturer’s instructions. A tdTomato-positive,
male, karyotypically normal line, competent for chimera generation as assessed using
morula aggregation assay, was selected for targeting Gata1. Two guides were designed
using the http://crispr.mit.edu tool (guide 1: CGGCTACTCCACTGTGGCGG; guide 2:
CGCTTCTTGGGCCGGATGAG) and were cloned into the pX458 plasmid (Addgene,
#48138) as previously described [56]. The obtained plasmids were then used to trans-
fect the cells, and single transfected clones were expanded and assessed for Cas9-
induced mutations. Genomic DNA was isolated by incubating cell pellets in 0.1 mg/ml
of Proteinase K (Sigma, #03115828001) in TE buffer at 50 °C for 2 h, followed by 5 min
at 99 °C. The sequence flanking the guide-targeted sites was amplified from the gen-
omic DNA by polymerase chain reaction (PCR) in a Biometra T3000 Thermocycler
(30 s at 98 °C; 30 cycles of 10 s at 98 °C, 20 s at 58 °C, 20 s at 72 °C; and elongation for 7
min at 72 °C) using the Phusion High-Fidelity DNA Polymerase (NEB, #M0530S) ac-
cording to the manufacturer’s instructions. Primers including Nextera overhangs were
used (F-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGTCTACCCTGCCTC
AACTGTG; R-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGTCTTGTCT
TGGGCAGGAACA), allowing library preparation with the Nextera XT Kit (Illumina,
#15052163), and sequencing was performed using the Illumina MiSeq system according
to the manufacturer’s instructions. An ESC clone showing a 38 base-pair frameshift
mutation in exon 4 resulting in the functional inactivation of Gata1 were selected for
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injection into C57BL/6 E3.5 blastocysts. A total of 6 chimeric embryos were harvested
at E8.5, dissected, and single-cell suspensions were generated by TrypLE Express dis-
sociation reagent (Thermo Fisher Scientific) incubation for 7–10min at 37 °C under
agitation. Single-cell suspensions were sorted into tdTom+ and tdTom− samples using
a BD Influx sorter with DAPI at 1 μg/ml (Sigma) as a viability stain for subsequent 10X
scRNA-Seq library preparation (version 3 chemistry), and sequencing using an S1 flow
cell in the Illumina Novaseq platform, which resulted in 8420 tdTom− and 7944
tdTom+ cells that passed quality control (see “Single-cell RNA sequencing analysis”
below).
Single-cell RNA sequencing analysis
Raw files were processed with Cell Ranger 3.0.2 using default mapping arguments.
Reads were mapped to the mm10 genome and counted with GRCm38.92 annotation,
including tdTomato sequence for chimera cells. Cell barcodes with expression profiles
significantly different to the ambient mRNA expression profile were identified using
emptyDrops [57], and cell barcodes with low complexity, i.e., low total mRNA counts
and/or high mitochondrial proportion, were identified by fitting four-component bivari-
ate mixture models to the log10-transformed total mRNA counts and percentage of
mitochondrial counts, and selecting the components with high total mRNA and low
mitochondrial percentage. Gene expression normalization and doublet cell barcodes
were identified using the approach taken by Pijuan-Sala et al. [25]. Both spliced and
unspliced count matrices were extracted using velocyto 0.17.17 [10].
Mapping to the reference dataset
We mapped the chimera cells to the mouse atlas following almost exactly the proced-
ure used in the original publication article to map the Tal1 chimera [25]. First, we
concatenated the mouse atlas and chimera counts (both previously controlled for qual-
ity of the cells), normalized the resulting counts matrix with scran, computed HVGs
and then applied multiBatchPCA, and reducedMNN with cosine normalization from
batchelor [50] for batch effect correction within samples (where sample refers to a sin-
gle lane of a 10x Chromium chip) as well as between datasets in order to extract a
number of nearest neighbours between the mouse atlas and the chimera using quer-
yKNN from BiocNeighbors package v1.6.0.
Differential gene expression analysis
For differential gene expression analysis, we took samples that included at least 7 cells
per tdTom status per cell population (e.g., Erythroid3). We ran the analysis in scanpy
v1.5.1 [58] with Wilcoxon test and choosing 2 as fold change and 0.1 as false discovery
rate thresholds.
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